Compare GNTA & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNTA | NYC |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | Italy | United States |
| Employees | 13 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9M | 23.5M |
| IPO Year | N/A | 2014 |
| Metric | GNTA | NYC |
|---|---|---|
| Price | $0.68 | $8.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 65.7K | 870.0 |
| Earning Date | 03-24-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.40 |
| Revenue Next Year | N/A | $1.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.59 | $7.03 |
| 52 Week High | $10.00 | $16.30 |
| Indicator | GNTA | NYC |
|---|---|---|
| Relative Strength Index (RSI) | 39.91 | 44.01 |
| Support Level | $0.60 | $7.12 |
| Resistance Level | $0.91 | $8.28 |
| Average True Range (ATR) | 0.10 | 0.30 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 21.78 | 9.18 |
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.